Relpax price
Executive Summary
Pfizer launches migraine agent Relpax (eletriptan) at $15.80 per tablet; packages of 12 tablets of either strength (20 mg or 40 mg) list for $189.60 AWP. The price is a slight discount to GSK's Imitrex (sumatriptan), which lists for $17.17 per 50 mg tablet. FDA approved Relpax Dec. 26 (1"The Pink Sheet" Jan. 6, p. 5)...
You may also be interested in...
Pfizer Relpax To Launch In First Quarter At Maximum Dose Of 40 Mg
Pfizer's Relpax migraine treatment will be launched during the first quarter at a maximum dose of 40 mg
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.